DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,244 filers reported holding DANAHER CORPORATION in Q2 2018. The put-call ratio across all filers is 0.63 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $627 | -4.1% | 2,541 | -4.2% | 0.03% | -5.7% |
Q1 2024 | $654 | +6.0% | 2,652 | -0.6% | 0.04% | 0.0% |
Q4 2023 | $617 | -7.1% | 2,668 | -1.0% | 0.04% | -14.6% |
Q3 2023 | $664 | +3.6% | 2,696 | +0.5% | 0.04% | +5.1% |
Q2 2023 | $641 | -6.4% | 2,683 | -0.5% | 0.04% | -11.4% |
Q1 2023 | $685 | -6.0% | 2,697 | -1.6% | 0.04% | -10.2% |
Q4 2022 | $729 | -99.9% | 2,740 | -10.2% | 0.05% | -14.0% |
Q3 2022 | $788,000 | +25.1% | 3,051 | +23.6% | 0.06% | +29.5% |
Q2 2022 | $630,000 | -13.1% | 2,469 | -0.2% | 0.04% | -6.4% |
Q1 2022 | $725,000 | -9.0% | 2,474 | +1.8% | 0.05% | -4.1% |
Q4 2021 | $797,000 | +6.4% | 2,431 | -1.1% | 0.05% | 0.0% |
Q3 2021 | $749,000 | +11.1% | 2,459 | -2.0% | 0.05% | +8.9% |
Q2 2021 | $674,000 | +19.1% | 2,509 | -0.3% | 0.04% | +15.4% |
Q1 2021 | $566,000 | +1.3% | 2,517 | 0.0% | 0.04% | -4.9% |
Q4 2020 | $559,000 | +5.9% | 2,517 | +2.6% | 0.04% | -4.7% |
Q3 2020 | $528,000 | +37.1% | 2,453 | +12.7% | 0.04% | +22.9% |
Q2 2020 | $385,000 | +54.0% | 2,177 | +20.9% | 0.04% | +34.6% |
Q1 2020 | $250,000 | -12.6% | 1,800 | -3.3% | 0.03% | -3.7% |
Q4 2019 | $286,000 | +6.3% | 1,862 | -0.3% | 0.03% | 0.0% |
Q3 2019 | $269,000 | -4.3% | 1,868 | -5.0% | 0.03% | -6.9% |
Q2 2019 | $281,000 | +8.5% | 1,966 | 0.0% | 0.03% | +3.6% |
Q1 2019 | $259,000 | +4.0% | 1,966 | -18.5% | 0.03% | -3.4% |
Q4 2018 | $249,000 | -5.0% | 2,411 | 0.0% | 0.03% | +3.6% |
Q3 2018 | $262,000 | +10.1% | 2,411 | 0.0% | 0.03% | +3.7% |
Q2 2018 | $238,000 | +0.8% | 2,411 | 0.0% | 0.03% | -6.9% |
Q1 2018 | $236,000 | +8.3% | 2,411 | +2.6% | 0.03% | +7.4% |
Q4 2017 | $218,000 | +29.8% | 2,350 | +19.8% | 0.03% | +17.4% |
Q3 2017 | $168,000 | -5.1% | 1,962 | -6.8% | 0.02% | -11.5% |
Q2 2017 | $177,000 | -1.7% | 2,105 | 0.0% | 0.03% | -7.1% |
Q1 2017 | $180,000 | -35.9% | 2,105 | -41.7% | 0.03% | -40.4% |
Q4 2016 | $281,000 | +10.2% | 3,610 | +10.8% | 0.05% | +4.4% |
Q3 2016 | $255,000 | -22.7% | 3,258 | -0.2% | 0.04% | -27.4% |
Q2 2016 | $330,000 | +6.8% | 3,264 | 0.0% | 0.06% | +3.3% |
Q1 2016 | $309,000 | +1.6% | 3,264 | -0.3% | 0.06% | -4.8% |
Q4 2015 | $304,000 | +9.0% | 3,274 | -0.1% | 0.06% | +6.8% |
Q3 2015 | $279,000 | +4.1% | 3,277 | +4.7% | 0.06% | +11.3% |
Q2 2015 | $268,000 | -1.8% | 3,130 | -2.4% | 0.05% | -1.9% |
Q1 2015 | $273,000 | +2.6% | 3,208 | +3.2% | 0.05% | -1.8% |
Q4 2014 | $266,000 | +12.2% | 3,108 | -0.1% | 0.06% | +14.6% |
Q3 2014 | $237,000 | -3.3% | 3,110 | -0.4% | 0.05% | 0.0% |
Q2 2014 | $245,000 | +4.3% | 3,121 | -0.1% | 0.05% | +2.1% |
Q1 2014 | $235,000 | 0.0% | 3,124 | +2.9% | 0.05% | -2.1% |
Q4 2013 | $235,000 | +11.4% | 3,037 | -0.2% | 0.05% | 0.0% |
Q3 2013 | $211,000 | +9.9% | 3,043 | -0.2% | 0.05% | +4.3% |
Q2 2013 | $192,000 | – | 3,049 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |